{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,3]],"date-time":"2026-10-03T04:28:56Z","timestamp":1791001736990,"version":"4.1.0"},"reference-count":57,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2022,6,1]],"date-time":"2022-06-01T00:00:00Z","timestamp":1654041600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,6,1]],"date-time":"2022-06-01T00:00:00Z","timestamp":1654041600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,2,26]],"date-time":"2022-02-26T00:00:00Z","timestamp":1645833600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["22077086"],"award-info":[{"award-number":["22077086"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81230077"],"award-info":[{"award-number":["81230077"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81872729"],"award-info":[{"award-number":["81872729"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100013313","name":"Overseas Expertise Introduction Project for Discipline Innovation","doi-asserted-by":"publisher","award":["D20029"],"award-info":[{"award-number":["D20029"]}],"id":[{"id":"10.13039\/501100013313","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Acta Pharmaceutica Sinica B"],"published-print":{"date-parts":[[2022,6]]},"DOI":"10.1016\/j.apsb.2022.02.029","type":"journal-article","created":{"date-parts":[[2022,3,4]],"date-time":"2022-03-04T12:43:10Z","timestamp":1646397790000},"page":"2905-2922","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":29,"title":["Synthesis of selective PAK4 inhibitors for lung metastasis of lung cancer and melanoma cells"],"prefix":"10.1016","volume":"12","author":[{"given":"Peilu","family":"Song","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5745-5271","authenticated-orcid":false,"given":"Fan","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6964-4619","authenticated-orcid":false,"given":"Dahong","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiqiang","family":"Qu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miao","family":"Yao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuan","family":"Su","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hanxun","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miaomiao","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yujie","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7841-2089","authenticated-orcid":false,"given":"Yinli","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Feng","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dongmei","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fengjiao","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu","family":"Rao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8408-7788","authenticated-orcid":false,"given":"Mingyu","family":"Xia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haitao","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jian","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9073-4806","authenticated-orcid":false,"given":"Maosheng","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.apsb.2022.02.029_bib1","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1016\/S1357-2725(98)00059-4","article-title":"The p21Rac\/Cdc42-activated kinases (PAKs)","volume":"30","author":"Knaus","year":"1998","journal-title":"Int J Biochem Cell Biol"},{"key":"10.1016\/j.apsb.2022.02.029_bib2","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1042\/BC20070109","article-title":"A tale of two PAKs","volume":"100","author":"Arias-Romero","year":"2008","journal-title":"Biol Cell"},{"key":"10.1016\/j.apsb.2022.02.029_bib3","doi-asserted-by":"crossref","first-page":"6527","DOI":"10.1093\/emboj\/17.22.6527","article-title":"PAK4, a novel effector for Cdc42Hs, is implicated in the reorganization of the actin cytoskeleton and in the formation of filopodia","volume":"17","author":"Abo","year":"1998","journal-title":"EMBO J"},{"key":"10.1016\/j.apsb.2022.02.029_bib4","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/j.gene.2016.12.014","article-title":"Structure, biochemistry, and biology of PAK kinases","volume":"605","author":"Kumar","year":"2017","journal-title":"Gene"},{"key":"10.1016\/j.apsb.2022.02.029_bib5","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1021\/jm501613q","article-title":"Inhibitors of p21-activated kinases (PAKs)","volume":"58","author":"Rudolph","year":"2015","journal-title":"J Med Chem"},{"key":"10.1016\/j.apsb.2022.02.029_bib6","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/j.semcancer.2018.01.006","article-title":"p21-activated kinase signaling in cancer","volume":"54","author":"Rane","year":"2019","journal-title":"Semin Cancer Biol"},{"key":"10.1016\/j.apsb.2022.02.029_bib7","doi-asserted-by":"crossref","first-page":"105","DOI":"10.4161\/cl.21882","article-title":"PAK signaling in cancer","volume":"2","author":"Ye","year":"2012","journal-title":"Cell Logist"},{"key":"10.1016\/j.apsb.2022.02.029_bib8","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1038\/nrc3645","article-title":"PAK signalling during the development and progression of cancer","volume":"14","author":"Radu","year":"2014","journal-title":"Nat Rev Cancer"},{"key":"10.1016\/j.apsb.2022.02.029_bib9","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41467-019-11510-4","article-title":"PAK4 suppresses RELB to prevent senescence-like growth arrest in breast cancer","volume":"10","author":"Costa","year":"2019","journal-title":"Nat Commun"},{"key":"10.1016\/j.apsb.2022.02.029_bib10","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1158\/0008-5472.CAN-20-0854","article-title":"Targeting PAK4 inhibits Ras-mediated signaling and multiple oncogenic pathways in high-risk Rhabdomyosarcoma","volume":"81","author":"Dasgupta","year":"2021","journal-title":"Cancer Res"},{"key":"10.1016\/j.apsb.2022.02.029_bib11","doi-asserted-by":"crossref","first-page":"8778","DOI":"10.18632\/oncotarget.2398","article-title":"p-21 activated kinase 4 promotes proliferation and survival of pancreatic cancer cells through AKT- and ERK-dependent activation of NF-kappaB pathway","volume":"5","author":"Tyagi","year":"2014","journal-title":"Oncotarget"},{"key":"10.1016\/j.apsb.2022.02.029_bib12","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1158\/1541-7786.MCR-12-0466","article-title":"Knockdown of PAK4 or PAK1 inhibits the proliferation of mutant KRAS colon cancer cells independently of RAF\/MEK\/ERK and PI3K\/AKT signaling","volume":"11","author":"Tabusa","year":"2013","journal-title":"Mol Cancer Res"},{"key":"10.1016\/j.apsb.2022.02.029_bib13","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1038\/31735","article-title":"Cofilin phosphorylation by LIM-kinase 1 and its role in Rac-mediated actin reorganization","volume":"393","author":"Yang","year":"1998","journal-title":"Nature"},{"key":"10.1016\/j.apsb.2022.02.029_bib14","doi-asserted-by":"crossref","first-page":"18622","DOI":"10.1073\/pnas.0907481107","article-title":"p21-activated kinase 4 regulates ovarian cancer cell proliferation, migration, and invasion and contributes to poor prognosis in patients","volume":"107","author":"Siu","year":"2010","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.apsb.2022.02.029_bib15","doi-asserted-by":"crossref","first-page":"43853","DOI":"10.18632\/oncotarget.6081","article-title":"p21-activated kinase group II small compound inhibitor GNE-2861 perturbs estrogen receptor alpha signaling and restores tamoxifen-sensitivity in breast cancer cells","volume":"6","author":"Zhuang","year":"2015","journal-title":"Oncotarget"},{"key":"10.1016\/j.apsb.2022.02.029_bib16","doi-asserted-by":"crossref","DOI":"10.1042\/BSR20130102","article-title":"PAK4 confers cisplatin resistance in gastric cancer cells via PI3K\/Akt- and MEK\/ERK-dependent pathways","volume":"34","author":"Fu","year":"2014","journal-title":"Biosci Rep"},{"key":"10.1016\/j.apsb.2022.02.029_bib17","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1080\/21541248.2017.1329694","article-title":"Targeting Rho GTPase effector p21 activated kinase 4 (PAK4) suppresses p-Bad-microRNA drug resistance axis leading to inhibition of pancreatic ductal adenocarcinoma proliferation","volume":"10","author":"Mohammad","year":"2019","journal-title":"Small GTPases"},{"key":"10.1016\/j.apsb.2022.02.029_bib18","first-page":"46","article-title":"PAK4 inhibition improves PD-1 blockade immunotherapy","volume":"1","author":"Abril-Rodriguez","year":"2019","journal-title":"Nat Can"},{"key":"10.1016\/j.apsb.2022.02.029_bib19","first-page":"18","article-title":"PAK4 as a cancer immune-evasion target","volume":"1","author":"Gajewski","year":"2020","journal-title":"Nat Can"},{"key":"10.1016\/j.apsb.2022.02.029_bib20","first-page":"83","article-title":"Targeting PAK4 to reprogram the vascular microenvironment and improve CAR-T immunotherapy for glioblastoma","volume":"2","author":"Ma","year":"2020","journal-title":"Nat Can"},{"key":"10.1016\/j.apsb.2022.02.029_bib21","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1021\/jm401768t","article-title":"Back pocket flexibility provides group II p21-activated kinase (PAK) selectivity for type I 1\/2 kinase inhibitors","volume":"57","author":"Staben","year":"2014","journal-title":"J Med Chem"},{"key":"10.1016\/j.apsb.2022.02.029_bib22","doi-asserted-by":"crossref","first-page":"4728","DOI":"10.1021\/jm300204j","article-title":"Discovery of pyrroloaminopyrazoles as novel PAK inhibitors","volume":"55","author":"Guo","year":"2012","journal-title":"J Med Chem"},{"key":"10.1016\/j.apsb.2022.02.029_bib23","doi-asserted-by":"crossref","first-page":"2580","DOI":"10.1016\/j.bmcl.2016.04.037","article-title":"The discovery and the structural basis of an imidazo[4,5-b]pyridine-based p21-activated kinase 4 inhibitor","volume":"26","author":"Park","year":"2016","journal-title":"Bioorg Med Chem Lett"},{"key":"10.1016\/j.apsb.2022.02.029_bib24","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1517\/13543776.2012.668758","article-title":"p21-Activated kinase inhibitors: a patent review","volume":"22","author":"Crawford","year":"2012","journal-title":"Expert Opin Ther Pat"},{"key":"10.1016\/j.apsb.2022.02.029_bib25","doi-asserted-by":"crossref","first-page":"9446","DOI":"10.1073\/pnas.0911863107","article-title":"Small-molecule p21-activated kinase inhibitor PF-3758309 is a potent inhibitor of oncogenic signaling and tumor growth","volume":"107","author":"Murray","year":"2010","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.apsb.2022.02.029_bib26","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1016\/S0959-8049(14)70606-9","article-title":"Identification of novel small molecules as selective PAK4 allosteric modulators (PAMs) by stable isotope labeling of amino acids in cells (SILAC)","volume":"50","author":"Senapedis","year":"2014","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.apsb.2022.02.029_bib27","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1186\/s13045-021-01107-0","article-title":"Anti-tumor NAMPT inhibitor, KPT-9274, mediates gender-dependent murine anemia and nephrotoxicity by regulating SIRT3-mediated SOD deacetylation","volume":"14","author":"Mitchell","year":"2021","journal-title":"J Hematol Oncol"},{"key":"10.1016\/j.apsb.2022.02.029_bib28","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1158\/1535-7163.MCT-16-0205","article-title":"Novel p21-activated kinase 4 (PAK4) allosteric modulators overcome drug resistance and stemness in pancreatic ductal adenocarcinoma","volume":"16","author":"Aboukameel","year":"2017","journal-title":"Mol cancer ther"},{"key":"10.1016\/j.apsb.2022.02.029_bib29","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1021\/acs.jmedchem.7b01342","article-title":"Structure-based design of 6-chloro-4-aminoquinazoline-2-carboxamide derivatives as potent and selective p21-activated kinase 4 (PAK4) inhibitors","volume":"61","author":"Hao","year":"2018","journal-title":"J Med Chem"},{"key":"10.1016\/j.apsb.2022.02.029_bib30","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/j.ejmech.2018.05.051","article-title":"Design, synthesis, structure\u2012activity relationships study and X-ray crystallography of 3-substituted-indolin-2-one-5-carboxamide derivatives as PAK4 inhibitors","volume":"155","author":"Guo","year":"2018","journal-title":"Eur J Med Chem"},{"key":"10.1016\/j.apsb.2022.02.029_bib31","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ejmech.2017.02.063","article-title":"Development of 2,4-diaminoquinazoline derivatives as potent PAK4 inhibitors by the core refinement strategy","volume":"131","author":"Hao","year":"2017","journal-title":"Eur J Med Chem"},{"key":"10.1016\/j.apsb.2022.02.029_bib32","doi-asserted-by":"crossref","first-page":"3803","DOI":"10.1039\/C5OB00037H","article-title":"Design, synthesis and biological evaluation of 1-phenanthryl-tetrahydroisoquinoline derivatives as novel p21-activated kinase 4 (PAK4) inhibitors","volume":"13","author":"Song","year":"2015","journal-title":"Org Biomol Chem"},{"key":"10.1016\/j.apsb.2022.02.029_bib33","doi-asserted-by":"crossref","first-page":"2681","DOI":"10.1021\/jm901443h","article-title":"Through the \"gatekeeper door\": exploiting the active kinase conformation","volume":"53","author":"Zuccotto","year":"2010","journal-title":"J Med Chem"},{"key":"10.1016\/j.apsb.2022.02.029_bib34","doi-asserted-by":"crossref","first-page":"6465","DOI":"10.1021\/jm060434q","article-title":"N-(5-Chloro-1,3-benzodioxol-4-yl)-7-[2-(4-methylpiperazin-1-yl) ethoxy]-5-(tetrahydro-2H-pyran-4-yloxy) quinazolin-4-amine, a novel, highly selective, orally available, dual-specific c-Src\/Abl kinase inhibitor","volume":"49","author":"Hennequin","year":"2006","journal-title":"J Med Chem"},{"key":"10.1016\/j.apsb.2022.02.029_bib35","doi-asserted-by":"crossref","first-page":"1633","DOI":"10.1016\/j.bmcl.2005.12.028","article-title":"Inhibitors of epidermal growth factor receptor tyrosine kinase: novel C-5 substituted anilinoquinazolines designed to target the ribose pocket","volume":"16","author":"Ballard","year":"2006","journal-title":"Bioorg Med Chem Lett"},{"key":"10.1016\/j.apsb.2022.02.029_bib36","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1021\/jm0608107","article-title":"Molecular recognition of protein kinase binding pockets for design of potent and selective kinase inhibitors","volume":"50","author":"Liao","year":"2007","journal-title":"J Med Chem"},{"key":"10.1016\/j.apsb.2022.02.029_bib37","doi-asserted-by":"crossref","first-page":"5121","DOI":"10.1021\/acs.jmedchem.5b00572","article-title":"Structure-guided design of group I selective p21-activated kinase inhibitors","volume":"58","author":"Crawford","year":"2015","journal-title":"J Med Chem"},{"key":"10.1016\/j.apsb.2022.02.029_bib38","doi-asserted-by":"crossref","first-page":"6801","DOI":"10.1021\/acs.jmedchem.8b00678","article-title":"Scaffold-hopping approach to discover potent, selective, and efficacious inhibitors of NF-kappaB inducing kinase","volume":"61","author":"Blaquiere","year":"2018","journal-title":"J Med Chem"},{"key":"10.1016\/j.apsb.2022.02.029_bib39","doi-asserted-by":"crossref","first-page":"5625","DOI":"10.1021\/acs.jmedchem.9b01617","article-title":"Acetylene group, friend or foe in medicinal chemistry","volume":"63","author":"Talele","year":"2020","journal-title":"J Med Chem"},{"key":"10.1016\/j.apsb.2022.02.029_bib40","doi-asserted-by":"crossref","first-page":"6465","DOI":"10.1021\/jm060434q","article-title":"N-(5-Chloro-1,3-benzodioxol-4-yl)-7-[2-(4-methylpiperazin-1-yl)ethoxy]-5-(tetrahydro-2H-pyran-4-yloxy)quinazolin-4-amine, a novel, highly selective, orally available, dual-specific c-Src\/Abl kinase inhibitor","volume":"49","author":"Hennequin","year":"2006","journal-title":"J Med Chem"},{"key":"10.1016\/j.apsb.2022.02.029_bib41","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.canlet.2014.03.024","article-title":"Discovery and the structural basis of a novel p21-activated kinase 4 inhibitor","volume":"349","author":"Ryu","year":"2014","journal-title":"Cancer Lett"},{"key":"10.1016\/j.apsb.2022.02.029_bib42","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1074\/jbc.M105732200","article-title":"Requirement for PAK4 in the anchorage-independent growth of human cancer cell lines","volume":"277","author":"Callow","year":"2002","journal-title":"J Biol Chem"},{"key":"10.1016\/j.apsb.2022.02.029_bib43","doi-asserted-by":"crossref","first-page":"1385","DOI":"10.1038\/jid.2014.548","article-title":"p21-activated kinase 4 critically regulates melanogenesis via activation of the CREB\/MITF and \u03b2-Catenin\/MITF pathways","volume":"135","author":"Yun","year":"2015","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.apsb.2022.02.029_bib44","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1186\/s13046-015-0165-2","article-title":"Overexpression of P21-activated kinase 4 is associated with poor prognosis in non-small cell lung cancer and promotes migration and invasion","volume":"34","author":"Cai","year":"2015","journal-title":"J Exp Clin Cancer Res"},{"key":"10.1016\/j.apsb.2022.02.029_bib45","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aaw8412","article-title":"Off-target toxicity is a common mechanism of action of cancer drugs undergoing clinical trials","volume":"11","author":"Lin","year":"2019","journal-title":"Sci Transl Med"},{"key":"10.1016\/j.apsb.2022.02.029_bib46","doi-asserted-by":"crossref","first-page":"766","DOI":"10.1016\/j.trecan.2019.10.003","article-title":"Multiscale imaging of metastasis in zebrafish","volume":"5","author":"Osmani","year":"2019","journal-title":"Trends Cancer"},{"key":"10.1016\/j.apsb.2022.02.029_bib47","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1038\/nrd1606","article-title":"In\u00a0vivo drug discovery in the zebrafish","volume":"4","author":"Zon","year":"2005","journal-title":"Nat Rev Drug Discov"},{"key":"10.1016\/j.apsb.2022.02.029_bib48","doi-asserted-by":"crossref","first-page":"1243","DOI":"10.1016\/S0960-9822(07)00533-7","article-title":"TGF\u03b2 signaling is necessary for carcinoma cell invasiveness and metastasis","volume":"8","author":"Oft","year":"1998","journal-title":"Curr Biol"},{"key":"10.1016\/j.apsb.2022.02.029_bib49","doi-asserted-by":"crossref","first-page":"1305","DOI":"10.1172\/JCI30740","article-title":"Inhibition of TGF-beta with neutralizing antibodies prevents radiation-induced acceleration of metastatic cancer progression","volume":"117","author":"Biswas","year":"2007","journal-title":"J Clin Invest"},{"key":"10.1016\/j.apsb.2022.02.029_bib50","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/j.cell.2008.01.046","article-title":"TGF beta primes breast tumors for lung metastasis seeding through angiopoietin-like 4","volume":"133","author":"Padua","year":"2008","journal-title":"Cell"},{"key":"10.1016\/j.apsb.2022.02.029_bib51","doi-asserted-by":"crossref","first-page":"8430","DOI":"10.1073\/pnas.0932636100","article-title":"Transforming growth factor beta signaling impairs Neu-induced mammary tumorigenesis while promoting pulmonary metastasis","volume":"100","author":"Siegel","year":"2003","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.apsb.2022.02.029_bib52","first-page":"3026","article-title":"PAK4 enhances TGF-beta 1-induced epithelial-mesenchymal transition through activating beta-catenin signaling pathway in renal tubular epithelial cells","volume":"11","author":"Fan","year":"2018","journal-title":"Int J Clin Exp Pathol"},{"key":"10.1016\/j.apsb.2022.02.029_bib53","first-page":"3116","article-title":"The metastasis suppressor NDRG1 modulates the phosphorylation and nuclear translocation of beta-catenin through mechanisms involving FRAT1 and PAK4","volume":"127","author":"Jin","year":"2014","journal-title":"J Cell Sci"},{"key":"10.1016\/j.apsb.2022.02.029_bib54","doi-asserted-by":"crossref","first-page":"5309","DOI":"10.1038\/onc.2016.261","article-title":"A novel interaction of PAK4 with\u00a0PPARgamma to regulate Nox1 and radiation-induced epithelial-to-mesenchymal transition in glioma","volume":"36","author":"Kesanakurti","year":"2017","journal-title":"Oncogene"},{"key":"10.1016\/j.apsb.2022.02.029_bib55","doi-asserted-by":"crossref","first-page":"1383","DOI":"10.1158\/0008-5472.CAN-18-2575","article-title":"PAK4 phosphorylates fumarase and blocks TGFbeta-induced cell growth arrest in lung cancer cells","volume":"79","author":"Chen","year":"2019","journal-title":"Cancer Res"},{"key":"10.1016\/j.apsb.2022.02.029_bib56","doi-asserted-by":"crossref","first-page":"613","DOI":"10.4155\/fmc-2020-0381","article-title":"Kaempferol ameliorates the regulatory effects of PVT1\/miR-214 on epithelial-mesenchymal transition through the PAK4\/beta-catenin axis in SRA01\/04 cells","volume":"13","author":"Huang","year":"2021","journal-title":"Future Med Chem"},{"key":"10.1016\/j.apsb.2022.02.029_bib57","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1021\/ed080p214","article-title":"An intuitive look at the relationship of Ki and IC50: a more general use for the Dixon Plot","volume":"80","author":"Burlingham","year":"2003","journal-title":"J Chem Educ"}],"container-title":["Acta Pharmaceutica Sinica B"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2211383522000958?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2211383522000958?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T16:54:57Z","timestamp":1761929697000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2211383522000958"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,6]]},"references-count":57,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2022,6]]}},"alternative-id":["S2211383522000958"],"URL":"https:\/\/doi.org\/10.1016\/j.apsb.2022.02.029","relation":{},"ISSN":["2211-3835"],"issn-type":[{"value":"2211-3835","type":"print"}],"subject":[],"published":{"date-parts":[[2022,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Synthesis of selective PAK4 inhibitors for lung metastasis of lung cancer and melanoma cells","name":"articletitle","label":"Article Title"},{"value":"Acta Pharmaceutica Sinica B","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.apsb.2022.02.029","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Chinese Pharmaceutical Association and Institute of Materia Medica, Chinese Academy of Medical Sciences. Production and hosting by Elsevier B.V.","name":"copyright","label":"Copyright"}]}}